Volastra Therapeutics
New York, NY
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability.
volastratx.comCompany Details
Founded
- 2019
Employees
- Between 20 - 100 employees
Raised
- $119,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Charles Hugh-Jones
Founders
- Lewis CantleyOlivier ElementoSamuel Bakhoum
Company Collections
These are collections Volastra Therapeutics is a part of. Click on the collection name to view similar companies.